| Name | 2-[1-methoxy-1-[3-(naphthalen-2-ylmethoxy)phenyl]propyl]-1,3-thiazole |
|---|---|
| Synonyms | ICI 211965 |
| Description | ICI 211965 is a selective and orally potent 5-Lipoxygenase (5-LPO) inhibitor. |
|---|---|
| Related Catalog | |
| Target |
5-LPO[1] |
| In Vitro | ICI 211965 is a selective and orally potent 5-Lipoxygenase (5-LPO) inhibitor. ICI 211965 reduces the leakage of lactate dehydrogenase (LD) and lipid peroxidation at concentrations related to its antioxidative effect and not to its 5-1ipoxygenase-inhibiting effect[1]. |
| Cell Assay | The myocytes are plated on 35 mm plastic culture dishes at a density of approximately 9×105 cells/mL (1.8×106 cells/dish). The cells are kept in culture for 6 d at 37°C and 5% CO2 under aerobic conditions in a carbon dioxide incubator. During this period the cells are beating spontaneously at an approximate frequency of 20 to 40 beats/min. Each culture dish contains 0.9+0.2 mg protein. The antioxidant ICI 211965 is added to the culture medium at a final concentration of 0.1% ethanol. Cell damage is determined by leakage of lactate dehydrogenase (LD) to the medium, and is analyzed after 0.5, 1.0, 2.0, 3.0, and 5.0 h[1]. |
| References |
| Density | 1.19g/cm3 |
|---|---|
| Boiling Point | 544.2ºC at 760 mmHg |
| Molecular Formula | C24H23NO2S |
| Molecular Weight | 389.51000 |
| Flash Point | 282.9ºC |
| Exact Mass | 389.14500 |
| PSA | 59.59000 |
| LogP | 6.17530 |
| Vapour Pressure | 2.39E-11mmHg at 25°C |
| Index of Refraction | 1.629 |
| Storage condition | 2-8℃ |
| Precursor 8 | |
|---|---|
| DownStream 0 | |